Drug Profile
Etanercept biosimilar - PROBIOMED
Alternative Names: InfinitamLatest Information Update: 17 Nov 2021
Price :
$50
*
At a glance
- Originator PROBIOMED
- Class Anti-inflammatories; Antipsoriatics; Antirheumatics; Disease-modifying antirheumatics; Recombinant fusion proteins; Skin disorder therapies
- Mechanism of Action Immunomodulators; Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Rheumatoid arthritis
Most Recent Events
- 15 Jun 2013 Phase-III clinical trials in Rheumatoid arthritis in Mexico (SC)
- 15 Jun 2013 Adverse events and efficacy data from a phase III trial in Rhematoid arthritis presented at the 14th Annual Congress of the European League Against Rheumatism (EULAR-2013)